SemaThera

Business Services · Canada · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1 Av Du Mont-Royal O Suite 800, Montreal...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About SemaThera

SemaThera Inc. is focused on developing innovative treatments for diabetic and other retinal degenerative diseases, addressing the significant impact of diabetes on vision. The company has conducted over a decade of research into the role of semaphorin 3A in diabetic retinopathy, leading to the creation of biological traps that sequester harmful proteins and cytokines. Their products aim to reduce retinal vascular leakage, inflammation, and promote re-vascularization in affected patients. SemaThera collaborates with leading organizations, including a partnership with Roche, to advance their therapeutic solutions.Explore more
SemaThera's Social MediaPopular SearchesSemathera IncSematheraSIC Code 87,873NAICS Code 54,541Show more

SemaThera Org Chart

Garth Cumberlidge, President & Director & Chief Executive Officer at SemaThera
Canada flag for contact location.

President & Director & Chief Executive Office...

PhoneEmail
VB
Canada flag for contact location.

Consulting Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is SemaThera your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to SemaThera

Compare insights from companies similar to SemaThera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

SemaThera

<$5M
1-10
Private
-
2016
Garth Cumberlidge, President & Director & Chief Executive Officer at SemaThera
Garth CumberlidgePresident & Director & CEO
$6M
11-50
Public
$264M
2001
EK
Ewelina KulikowskiChief Scientific Officer
<$5M
11-50
Private
-
2006
RW
R. WongExecutive Chairman & President
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
Shairaz Baksh, President & Chief Executive Officer at BioImmuno Designs
Shairaz BakshPresident & CEO
<$5M
11-50
Public
$14.7M
2006
Jonathan Rigby, Board Member and Chief Executive Officer at Sernova Biotherapeutics
Jonathan RigbyBoard Member and CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

SemaThera is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

SemaThera is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SemaThera.

SemaThera Tech Stack

A closer look at the technologies used by SemaThera

Top Business Services Companies

Frequently Asked Questions Regarding SemaThera

What is SemaThera's official website?
SemaThera's official website is www.semathera.com
What is SemaThera's Revenue?
SemaThera's revenue is <$5 Million
What is SemaThera's SIC code?
SemaThera's SIC: 87,873
What is SemaThera's NAICS code?
SemaThera's NAICS: 54,541
How many employees does SemaThera have?
SemaThera has 1-10 employees
What industry does SemaThera belong to?
SemaThera is in the industry of: Business Services, Research & Development
What is SemaThera competition?
SemaThera top competitors include: BioImmuno Designs, Sernova Biotherapeutics, WK Lab, Medimabs
What technology does SemaThera use?
Some of the popular technologies that SemaThera uses are: WordPress.org, PHP, Google Cloud Web Serving, Google Cloud Platform
What does SemaThera do?

SemaThera Inc. is focused on developing innovative treatments for diabetic and other retinal degenerative diseases, addressing the significant impact of diabetes on vision. The company has conducted over a decade of research into the role of semaphorin 3A in diabetic retinopathy, leading to the creation of biological traps that sequester harmful pr... oteins and cytokines. Their products aim to reduce retinal vascular leakage, inflammation, and promote re-vascularization in affected patients. SemaThera collaborates with leading organizations, including a partnership with Roche, to advance their therapeutic solutions.Read More

What are SemaThera social media links?
SemaThera Linkedin page SemaThera Twitter page
Is SemaThera a public company?
SemaThera is private company therefore does not currently have an official ticker symbol
See more information about SemaThera

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.